Based on TCGA HNSCC tumor bulk dataset, patients with HNSCC had higher TIGIT, LAG3, and CD276 expression levels than healthy individuals (Fig 5E). This evidence concerns the gene LAG3 and head and neck squamous cell carcinoma.